Glaxosmithkline Pharmaceuticals board to consider unaudited financial results

17 Jul 2024 Evaluate
Glaxosmithkline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Friday, 2nd August 2024, to consider and approval of Un-audited financial results for the quarter ended 30th June 2024.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2464.90 -19.80 (-0.80%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×